BDBM674207 N-({(1r,4r)-4- [6-(2,3- dihydropyrazolo[5,1- b][1,3]oxazol-7-yl)- 2H-indazol-2-yl] cyclohexyl}methyl)- 3,5-difluoro-4- hydroxybenzamide::US20240150334, Example 37

SMILES Oc1c(F)cc(cc1F)C(=O)NC[C@H]1CC[C@@H](CC1)n1cc2ccc(cc2n1)-c1cnn2CCOc12

InChI Key InChIKey=BUXDXXAHOGJMSN-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 674207   

Target17-beta-hydroxysteroid dehydrogenase 13(Human)
Pfizer

US Patent
LigandPNGBDBM674207(N-({(1r,4r)-4- [6-(2,3- dihydropyrazolo[5,1- b][1,...)
Affinity DataIC50: 5.40nMAssay Description:HSD17B13 uses the oxidized form of nicotinamide adenine dinucleotide (NAD+) as a cofactor during metabolism of beta-estradiol (substrate), converting...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2024
Entry Details
Go to US Patent